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Abstract: Since manual palpation is a subjective procedure for identifying and differentiate Myofas-
cial Trigger Points -MTrPs-, the use of Shear Wave Elastography -SWE- as an objective alternative
is increasing. This study aimed to analyze pain pressure thresholds -PPTs- and SWE differences
between active MTrPs, latent MTrPs and control points located in the upper trapezius to analyze
the association of SWE features with clinical severity indicators (e.g., pain extension area, PPTs,
neck pain and neck disability). An observational study was conducted to calculate the correlation
and to analyze the differences of sociodemographic, clinical and SWE features on 34 asymptomatic
subjects with latent MTrPs and 19 patients with neck pain and active MTrPs. Significant PPT differ-
ences between active with latent MTrPs (p < 0.001) and control points (p < 0.001) were found, but
no differences between latent MTrPs and control points (p > 0.05). No stiffness differences were
found between active MTrPs with latent MTrPs or control points (p > 0.05). However, significant
control point stiffness differences between-samples were found (p < 0.05). SWE showed no significant
correlation with clinical severity indicators (p > 0.05). No stiffness differences between active and
latent MTrPs were found. Neck pain patients showed increased control point stiffness compared
with asymptomatic subjects. SWE showed no association with clinical severity indicators.
Keywords: myofascial pain syndromes; trigger points; neck pain; elasticity imaging techniques
1. Introduction
Neck pain is the fourth highest condition on number of years lived with disability with
a 20% of estimated prevalence, a lifetime prevalence up to the 70% and high recurrence [1].
Current evidence suggests that a higher prevalence of Myofascial Trigger Points -MTrP-
in the upper quarter muscles (e.g., upper trapezius, infraspinatus, and levator scapulae)
could be found in patients with chronic neck pain compared with healthy controls [2,3].
A MTrP is defined as “a hyperirritable spot in skeletal muscle that is associated with a
hypersensitive palpable nodule in a taut band. This spot is painful on manual compression
and can give rise to characteristic referred pain, referred tenderness, motor dysfunction and
autonomic phenomena” and could be classified as active (upon stimulation reproduce any
symptom experienced by the patient, either partially or completely, whereby the symptom
is recognized as a familiar experience by the patient, even though it may not be present at
the moment of the examination) or latent (upon stimulation do not reproduce any symptom
experienced by a subject, symptomatic or asymptomatic, and the subject does not recognize
the elicited symptom as familiar) based on previous histological, neurophysiological,
biochemical, sonographic and somatosensorial findings [4,5].
However, since the etiology of neck pain seems to be multifactorial [6], there is still
certain controversy about whether MTrP presence is a necessary condition for Myofascial
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Pain Syndrome -MPS- diagnosis. Although it has been found that the prevalence and
pain sensitivity of MTrPs are enough sensitive to make distinctions between patients with
chronic non-traumatic neck pain and healthy subjects, the evidence supporting the high
prevalence of active and latent MTrPs in patients with neck pain is based on few studies
with small sample sizes and design limitations [1].
Although several diagnostic modalities aimed to understand the MTrP pathophysi-
ology (assessed as texture-based, doppler and echo-intensity US features, microdialysis,
electromyography, infrared thermography and magnetic resonance imaging), the current
gold standard for the diagnosis of MTrP is the manual palpation [7]. However, since
there is no consensus regarding the physical findings associated with MPS, the diagnosis
accuracy is associated with the examiner clinical experience, index of suspicion, training
and palpation skills [8].
Shear-wave elastography -SWE- is a non-invasive imaging technology, sensitive to
tissue stiffness and develop to provide quantitative and objective data (e.g., Young mod-
ulus -kPa- and local shear wave speed -m/s-) [9] which has been used previously for
assessing MTrP characteristics and showing controversial findings [10–13]. Whereas strain
sonoelastography -SSE- was the first introduced elastography technique which measures
physical tissue displacement parallel to the applied normal stress [14], SWE provides a
more objective, reliable and valid method for quantifying muscle stiffness based on acous-
tically induced shear waves which travel perpendicularly to the compression waves with
variate velocity depending on tissue stiffness [15].
Since current literature assessing stiffness properties of MTrPs used heterogeneous
US sonoelastography methods and sample sizes are limited, the aims of this observational
study were (1) to analyze pain pressure thresholds -PPTs- and SWE (e.g., Young modulus
and shear-wave speed) differences between active MTrPs, latent MTrPs and control points
in both samples of healthy subjects and patients with chronic neck pain and (2) to analyze
the association of SWE features with MPS clinical severity indicators (e.g., pain extension
area, PPTs, neck pain and neck disability).
2. Materials and Methods
2.1. Study Design
An observational study was conducted to calculate (1) the SWE and PPT differences
between active MTrPs, latent MTrPs and control points and (2) the association of SWE
Young modulus and shear wave speed with sociodemographic features and clinical severity
indicators (e.g., pain extension area, PPTs, neck pain and neck disability). his study followed
the Strengthening the Reporting of Observational studies in Epidemiology (STROBE)
guidelines and checklist [16], was conducted according to the Declaration of Helsinki, and
approved by the by the Institutional Ethics Committee of Clinical Research of Francisco de
Vitoria University (UFV 38/2021).
2.2. Participants
Two consecutive samples of asymptomatic volunteers and patients with chronic neck
pain were screened for eligibility criteria via flyer announcements from February 2021 to
April 2021 from a private clinic located in Francisco de Vitoria University (Madrid, Spain).
To be eligible for participation, volunteers had to be aged from 18 to 65 years old. Specific
inclusion criteria for the asymptomatic sample were the bilateral presence of at least one
latent MTrP located in the upper trapezius muscle and absence of neck pain during the
previous 12 months. Specific inclusion criteria for the neck pain sample were presence of at
least one active MTrP in each side of the upper trapezius muscle, neck pain evolution of at
least 6 months, a Neck Disability Index (NDI) score > 8% and a Visual Analogue Scale (VAS)
score > 3. Exclusion criteria were being under medical, pharmacological or physiotherapy
treatment affecting pain perception or muscle tone 6 months previous to their inclusion,
traumatic diseases (e.g., whiplash associated disorders, fractures or fissures), previous neck
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surgeries, cervical radiculopathy or myelopathy and any other medical condition (e.g.,
fibromyalgia or tumour).
2.3. Asessments
Sociodemographic data (e.g., sex, age, height, weight and body mass index) was
collected by using a standardized history. In addition, prior to the subjects’ participation in
the study, neck pain intensity and neck disability were assessed. A 100 mm VAS was used
for assessing the neck pain intensity. In this scale, “0” means complete absence of pain and
“100” the worst imaginable pain. Cut-off scores were interpreted as follows: VAS < 34: mild
pain, 35 < VAS < 64: moderate and 65 < VAS: severe [17]. Since the Neck Disability Index
(NDI) is a valid tool for measuring perceived disability associated with neck pain [18],
it was used for assessing the neck disability. This self-reported questionnaire consists of
10 items with a final score ranging 0-to-50 and expressed as percentage. Scores ranging
0–8% were considered as no disability, 10–28% as mild disability, 30–48% as moderate,
50–68% as severe and 70–100% as complete disability [19].
2.3.1. Blinding
To ensure the methodological quality, three different blinded assessors were involved
in this study: (1) The first assessor located and marked location of the points (control point,
active MTrP and latent MTrP); (2) The second assessor measured the PPTs blinded to the
participants’ group (symptomatic/asymptomatic) and point category (control point, active
MTrP or latent MTrP); (3) The third assessor performed the SWE assessment blinded to the
participants’ group, point category and PPT score.
2.3.2. Myofascial Trigger Points Identification
Since manual palpation if performed by an experienced clinician is considered to
reliably identify MTrP locations in the upper trapezius muscle by using a palpation proto-
col [20], a single experienced clinician (more than 10 years of experience in the assessment
and treatment of MPS) conducted a physical examination to confirm the active or latent
MTrP location by using a manual palpation protocol and assessment of the responses of the
patients about specific questions about painful symptoms following the criteria for identi-
fying active and latent MTrPs provided by Fernández-de-las-Peñas and Dommerholt [4]:
Participants were placed in the prone position and the examiner assessed bilaterally
the entire length of the upper trapezius muscle by using a pincer palpation to locate (1)
a palpable taut band, (2) a hypersensitive tender spot in the taut band and (3) a local
twitch response provoked by the snapping palpation of the taut band. MTrPs that upon
stimulation reproduced partially or totally familiar symptoms experienced by the patients
were considered active MTrPs and those that upon stimulation did not reproduce any
symptom experienced and the subject did not recognize the elicited symptom as familiar
was considered as a latent MTrP [4]. If there was more than one active MTrP, the most
symptomatic site was selected and marked with a blue skin marking pen. Then, a control
point located 3 cm laterally to the MTrP following the fibers direction (within the taut band)
was also marked with the same blue skin marking pen (Figure 1).
We selected this control point location based on the pain difference during the manual
palpation and based on a previous study [21] reporting that there are electromyographic
differences between MTrPs and control points separated 1cm following the fibers direction
(within the same taut band) and located in the upper trapezius muscle (200 to 700 µV
and 10 µV respectively). Examiners were blinded to this assignation of MTrP and control
locations during the measurement procedures.
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Figure 1. (A) Participants positioning; (B) Measurement points location.
2.3.3. Shear Wave Elastography-Image Acquisition
All ultrasound assessments were performed by the same examiner with more than
10 years of experience in musculoskeletal evaluation. A Canon Aplio A with a PLT-1005-BT
14L5 (5–14 MHz) transducer (Canon Medical Corp, 1385 Shimoishigami, Otawara, Tochigi
324-8550, Japan) were used for all the images capturing and measuring procedures. All
participants were positioned in the same orientation used for the MTrP identification
protocol. Since the longitudinal plane showed higher intra- and inter-examiner reliability
(ICC = 0.66–0.74) than the transversal assessment [22], all images were acquired with the
transducer oriented longitudinally with the muscle fibers and positioning the center of the
probe over the MTrP and the control point locations. Two images were obtained from each
patient and measurement point to improve the accuracy of the measurements.
In order to avoid bias regarding the MTrP surface selection based on the stiffness scale,
regions of interest (ROIs) for shear wave data were positioned to cover (1) the superficial
and deep internal echogenic fascia of upper trapezius (in order to include completely
the muscle thickness) and (2) 1 cm of width (correspondent with the algometer surface)
(Figure 2). Finally, both the Young Modulus and the Shear Wave Speed data were collected.
The sonographer was blinded to the sample group (symptomatic or asymptomatic) and
the point assessed (MTrP or control).
Figure 2. Shear Wave Elastography: Image measurement.
J. Clin. Med. 2021, 10, 2895 5 of 11
2.3.4. Pain Pressure Thresholds
Since algometry is a valid and reliable method for assessing pain sensitivity in the
upper trapezius muscle [23], both the MTrP and control point PPTs were assessed by using
a digital Wagner FDX algometer (with 1 cm2 surface area) increasing the pressure at a rate
of 1 kg/s by a different single assessor blinded to the participants group (symptomatic or
asymptomatic), PPT scores and point (MTrP or control). All participants received the same
standardized instructions, “I am going to push on your body at 2 places. If you feel pain,
not pressure, say ‘now’ and I will stop” [24]. The mean average of 3 trials was calculated
for each point (MTrP and control; right and left sides) and analyzed.
2.3.5. Pain Extent
For the calculation of the pain extent or pain area, a body chart was used since this
procedure showed good reliability (ICC = 0.74) to assess pain sites. Participants were asked
to paint with a red pen their pain area in 4 standard body chart images (anterior, both side
lateral and posterior views). Participants were supervised by one researcher to avoid extra
drawings. Then, all images were scanned with the same scanner, size and resolution to
be analyzed in tiff format by using the ImageJ software [25]. Finally, their pain area was
calculated as a percentage by dividing the red area by the total area of the 4 body charts
(Figure 3).
Figure 3. Body Chart used for pain extent.
2.4. Statistical Analysis
All statistical analyses were conducted in IBM SPSS Statistics V.25 for Mac OS (IBM
Corporation, Armonk, NY, USA) setting at a significance level p < 0.05. Firstly, normal
data distribution was verified by using the Shapiro-Wilk test. A descriptive analysis was
conducted to describe the sociodemographic and clinical characteristics of the sample, by
gender and by group (Symptomatic and Asymptomatic). Normal-distributed data were
described by means and standard deviation (SD). For sociodemographic characteristics,
between-groups differences by gender and group were assessed with Student t-test for inde-
pendent samples. PPT and SWE side-to-side, MTrP-control and between-groups differences
were also assessed by using Student t-tests. In order to assess the intra-examiner reliability
of SWE and PPT measurements, a 2-way mixed-model, consistency-type intra class corre-
lation coefficient (ICC3,1) was calculated. ICC scores were classified as fair (ICC < 0.50),
moderate (0.50 < ICC < 0.75), good (0.75 < ICC < 0.90) or excellent (0.90 < ICC) [26].
Pearson’s correlation coefficient was used to calculate a multivariable correlation
analysis between sociodemographic and clinical data. Pearson’s r scores were considered
as “poor” if r < 0.3, “fair” if 0.3 < r< 0.6, “moderate” if 0.6 < r < 0.8 and strong if 0.8 < r [27].
In addition, r coefficients were used to identify multicollinearity and shared variance
between the variables when r > 0.8.
J. Clin. Med. 2021, 10, 2895 6 of 11
3. Results
Sixty (n = 60) volunteers were initially recruited in April 2021. Five participants were
excluded due to: being under pharmacological treatment (n = 3), previous neck surgery
(n = 1) and radiculopathy diagnosis (n = 1). Fifty-three participants were finally included in
this study. Thirty-eight active MTrPs, sixty-eight latent MTrPs and one hundred-six control
points were analyzed. All neck pain patients (n = 19) showed bilateral active MTrP located
in the upper trapezius. None of the participants were lost or excluded during the study.
The intra-examiner reliability estimates were excellent for PPTs (ICC3,1 = 0.913–0.967) and
good-to-excellent for SWE (ICC3,1 = 0.868–0.927).
Table 1 describes sociodemographic characteristics of the total sample, by gender
and group. Although males presented significant BMI and height differences (p < 0.001)
compared with females, no sociodemographic differences for neck pain and asymptomatic
samples were found.
Table 1. Sociodemographic characteristics of the total sample, by gender, and group.
Subjects (n) Age (Years) Height(m) Weight(kg) BMI (kg/m2)
Total sample 53 21.7 ± 4.9 1.71 ± 0.09 67.3 ± 13.1 22.6 ± 2.9
Gender
Males 21 23.1 ± 2.8 1.79 ± 0.09 * 77.9 ± 11.9 * 24.0 ± 2.8 *
Females 32 20.8 ± 5.7 1.66 ± 0.09 60.5 ± 8.7 21.7 ± 2.6
Group
Neck Pain 19 21.5 ± 3.2 1.74 ± 0.07 74.1 ± 13.1 23.6 ± 3.0
Asymptomatic 34 21.9 ± 5.9 1.70 ± 0.10 64.0 ± 12.3 21.9 ± 2.6
* Significant differences between groups (p < 0.001).
Table 2 shows the PPT of latent MTrPs and control points of the asymptomatic sample
and the PPT of active MTrPs and control points, NDI, VAS and pain extent of the neck pain
patients. For asymptomatic subjects, latent MTrPs and control locations showed no PPT
differences (p > 0.05).
Table 2. Clinical characteristics of the participants.
Asymptomatic Subjects
PPT (kg/cm2)
NDI (%) VAS (0–100) Pain Extent (%)
MTrP a Control Difference
Mean 3.13 ± 1.09 3.55 ± 0.95 0.42 (−0.04; 0.89) - - -
Left 3.12 ± 1.19 3.37 ± 0.71 0.25 (−0.39; 0.90)
Right 3.14 ± 1.02 3.73 ± 1.13 0.59 (−0.11; 1.30)
Between sides difference 0.02 (−0.70; 0.75) 0.36 (−0.26; 0.98)
Neck Pain Subjects
Mean 1.84 ± 0.85 2.57 ± 1.40 0.73 (0.31;1.14) * 17.08± 7.49 41.8 ± 11.0 2.67 ± 1.60
Left 1.82 ± 0.88 2.50 ± 1.45 0.68 (0.05; 1.30) ‡
Right 1.86 ± 0.84 2.64 ± 1.37 0.78 (0.20; 1.36) †
Between sides difference 0.04 (−0.40; 0.48) 0.14 (−0.58; 0.86)
Between-Groups Differences
Mean 1.29 (0.90; 1.68) * 0.98 (0.46; 1.49) *
Left 1.30 (0.70; 1.89) * 0.87 (0.15; 1.59) ‡
Right 1.28 (0.74; 1.81) * 1.09 (0.33; 1.85) †
* p < 0.001; † p < 0.01; ‡ p < 0.05, a Latent MTrP for asymptomatic subjects and Active MTrP for neck pain subjects.
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Neck pain patients showed significant PPT differences between the active MTrP and
the control location (left side: p < 0.05; right side: p < 0.01; mean of both sides: p < 0.001).
No side-to-side differences were found for asymptomatic subjects (latent MTrP and control
point: p > 0.05) nor neck pain patients (active MTrP and control point: p > 0.05). In addition,
between-groups differences for latent and active MTrPs were found (left side, right side
and mean; p < 0.001). Finally, significant between-groups control point PPT differences
were found (left: p < 0.05; right: p < 0.01; mean: p < 0.001).
Table 3 summarizes Young Modulus and Shear Wave Speed of active MTrPs (symp-
tomatic sample), latent MTrPs (asymptomatic sample) and control locations (both samples).
No stiffness differences (assessed as Young modulus nor shear wave speed) were found
between latent MTrPs with control points (p > 0.05), active MTrPs with control points
(p > 0.05) nor latent MTrPs with active MTrPs (p > 0.05). In addition, no side-to-side differ-
ences were found in the active MTrPs, latent MTrPs or control points stiffness (all, p > 0.05).
However, significant between-groups differences were found for the Young modulus (right
side: p < 0.05) and shear wave speed (right side and mean of both sides: p < 0.05).
Table 3. Shear Wave Elastography Characteristics.
Asymptomatic Subjects
Young Modulus (kPa) Shear Wave Speed (m/s)
MTrP a Control Point Difference MTrP a Control Point Difference
Mean 14.77 ± 5.25 13.86 ± 3.00 0.91 (−1.04; 2.86) 2.06 ± 0.43 2.02 ± 0.29 0.03 (−0.12; 0.20)
Left 14.43 ± 6.23 14.01 ± 3.36 0.41 (−2.88; 3.71) 2.00 ± 0.50 2.01 ± 0.35 0.01 (−0.28; 0.29)
Right 15.11 ± 4.18 13.71 ± 2.68 1.40 (−0.91; 3.72) 2.12 ± 0.35 2.03 ± 0.22 0.08 (−0.10; 0.28)
Between sides
difference 0.68 (−2.81; 4.17) 0.30 (−2.30; 1.69) 0.12 (−0.16; 0.40) 0.02 (−0.16; 0.22)
Neck Pain Subjects
Mean 14.35 ± 4.22 15.48 ± 5.24 1.13 (−0.57; 2.83) 2.09 ± 0.32 2.17 ± 0.36 0.08 (−0.04; 0.20)
Left 13.61 ± 3.91 14.48 ± 4.14 0.86 (−1.21; 2.95) 2.02 ± 0.30 2.10 ± 0.30 0.07 (−0.08; 0.22)
Right 15.06 ± 4.44 16.45 ± 6.03 1.38 (−1.30; 4.07) 2.12 ± 0.34 2.24 ± 0.40 0.09 (−0.09; 0.28)
Between sides
difference 1.45 (−0.69; 3.60) 1.96 (−0.69; 4.62) 0.12 (−0.04; 0.28) 0.14 (−0.04; 0.32)
Between-Groups Differences
Mean 0.42 (−1.48; 2.32) 1.62 (−0.23; 3.47) 0.02 (−0.12; 0.17) 0.14 (0.00; 0.28) *
Left 0.81 (−2.09; 3.72) 0.46 (−1.80; 2.74) 0.02 (−0.20; 0.25) 0.08 (−0.10; 0.27)
Right 0.04 (−2.50; 2.59) 2.74 (−0.21; 5.69) * 0.02 (−0.18; 0.22) 0.20 (0.00; 0.40) *
* p < 0.05, a Latent MTrP for asymptomatic subjects and Active MTrP for neck pain subjects.
Data regarding the correlation analysis between sociodemographic, clinical and SWE
features are reported on Table 4. Young modulus showed no significant association with
the sociodemographic and clinical outcomes assessed (all, p > 0.05). Although shear wave
speed showed no association with clinical severity indicators (all, p > 0.05), it showed
to be negatively correlated with weight and BMI (p < 0.05 and p < 0.01 respectively).
Gender was associated with VAS (p < 0.01), PPT (p < 0.01), NDI (p < 0.01) and pain extent
(p < 0.05); height was associated with VAS (p < 0.01), PPT (p < 0.01), NDI (p < 0.05) and
pain extent (p < 0.05); weight was associated with VAS (p < 0.01), PPT (p < 0.01), and pain
extent (p < 0.01) but not with NDI (p > 0.05); BMI was associated with VAS (p < 0.05), PPT
(p < 0.01), and pain extent (p < 0.01) but not with NDI (p > 0.05) and age was not associated
with the clinical severity indicators assessed (all, p > 0.05).
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Table 4. Pearson-product moment correlation matrix.
1 2 3 4 5 6 7 8 9 10
1. Gender
2. Height −0.659 **
3. Weight −0.644 ** 0.752 **
4. BMI −0.381 ** 0.260 ** 0.826 **
5. Age −0.231 ** 0.174 * n.s. n.s.
6. Young Modulus n.s. n.s. n.s. n.s. n.s.
7. Shear Wave Speed n.s. n.s. −0.141 * −0.230 ** n.s. 0.937 **
8. VAS 0.324 ** −0.194 ** −0.230 ** −0.175 * n.s. n.s. n.s.
9. NDI 0.200 ** −0.152 * n.s. n.s. n.s. n.s. n.s. 0.859 **
10. PPT −0.386 ** 0.193 ** 0.258 ** 0.185 ** n.s. n.s. n.s. −0.417 ** −0.362 **
11. Pain Extent 0.177 * −0.195 * −0.273 ** −0.301 ** n.s. n.s. n.s. 0.295 ** 0.359 ** n.s.
n.s. non-significant, * p < 0.05; ** p < 0.01.
4. Discussion
4.1. Findings
This is the first study analyzing the clinical relevance of SWE as indicator of MPS
severity. In this study, (1) we compared the stiffness of neck pain patients with active MTrPs
with asymptomatic subjects with latent MTrPs, (2) we compared the stiffness of both latent
and active MTrPs with control points and (3) we conducted a correlation analysis between
stiffness assessed as Young modulus and shear wave speed and clinical severity assessed
as pain intensity, pain sensitivity, disability and pain extent. The most interesting finding of
this study was that, although there were important sensitivity differences between active
MTrPs with latent MTrPs and control points, we found no stiffness differences. However,
neck pain patients and asymptomatic subjects showed significant stiffness differences for
the control point.
Since MTrP are classically defined as hard palpable nodules within confirmed taut
bands [28] and are characterized by tenderness associated with pain [4], it would be logical
find stiffness and PPT differences between active MTrPs, latent MTrPs and control points
within the same muscle. However, even if MTrP showed an increased pain sensitivity
(lower PPT) compared with control point locations, we did not find stiffness differences
between active or latent MTrPs with control points. Our results are consistent with a
previous study since it was reported that the trapezius muscle hardness does not directly
reflect the subjective shoulder stiffness [29].
Since palpation is shown to be successful for identifying the most sensitive areas
(active and latent MTrPs), is the most popular diagnosis procedure used for assessing
stiffness differences. However, manual palpation is a high subjectivity test based on the
pain response of the patients which could imply bias and, therefore, objective methods
(with high sensitivity, specificity, reliability and validity) are prioritized [30]. Although
SWE is an objective alternative to manual palpation which showed to be a feasible tool
for assessing the upper trapezius muscle intra-session stiffness [22], the main limitation
found for this method is that its reliability showed to be moderate just if performed in
rigorous conditions (e.g., reporting both shear wave speed and young modulus assessed
in the longitudinal plane [31]. Therefore, those studies assessing transverse planes [32,33]
or using operator-dependent elastography methods (e.g., strain elastography) should be
interpreted carefully [11].
A previous study conducted by Ballyns et al. [11] reported no correlation between
trigger point areas and PPTs for either latent or active MTrPs. Therefore, even if they
found that active MTrPs show greater size compared with latent MTrPs, there are other
mechanisms contributing to the trigger point sensitivity such as sensitizing biochemicals as
reported by Shah et al. [34] derived from the capillary constriction consistent with Doppler
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US findings [11]. Our results are consistent with this hypothesis since we found in addition
to the sensitivity differences between healthy and clinical populations regarding the control
point locations, greater stiffness scores in neck pain patients.
We also found stiffness differences in the control point location between neck pain
patients and asymptomatic subjects. This is an interesting finding since the general muscle
stiffness showed to be a more differential factor compared with the MTrP stiffness. Future
studies could include the general muscle stiffness as an additional outcome to assess the
effects of different interventions on the general stiffness and its correlation with other
clinical features. In fact, emerging evidence is considering this proposal and considering
the SWE as a tool for clinical evaluation and monitorization of treatment responses [35].
Although our results suggest that SWE cannot be used as clinical severity indicator
or a tool to differentiate active and latent MTrPs based on Young modulus and shear
wave speed, this field requires further investigation to consolidate these findings. In fact,
we found no correlation between age and stiffness. One likely reason explaining the
discrepancy with the current evidence [36] is the small range of ages included in this study.
Therefore, our results cannot be extrapolated to the general population and further research
should consider greater ranges of age, height, weight, BMI and pain intensity/disability to
confirm these findings.
4.2. Limitations
Even if the results of this study are promising and we considered the blinding of the
assessors and the inclusion of one sample of asymptomatic subjects as a control group, some
potential limitations should be recognized. Firstly, we measured the locations stiffness just
in the longitudinal plane due to reliability restrictions previously reported. Since the image
assessed limited fibers and MTrP are located in taut bands, this could show increased
stiffness in the control points selected. Secondly, additional associations between SWE with
Doppler US, electromyography and biochemical analysis would clarify several aspects
of our findings and confirm the presence of active or latent MTrPs. Finally, the sample
was relatively small and further research including greater samples with wide standard
deviations is needed.
5. Conclusions
This study showed that active MTrPs located in the upper trapezius identified by
manual palpation in neck pain patients are more sensitive compared with control point
within the same muscle and with latent MTrPs in asymptomatic subjects. We found no
stiffness differences assessed as SWE Young modulus and shear wave speed between
active and latent MTrPs. However, neck pain patients showed increased control point
stiffness compared with asymptomatic subjects. Therefore, future studies could assess how
different interventions change the general muscle stiffness (not focusing just in MTrPs)
and its relevance during the clinical evaluation and follow-up by analyzing the correlation
between clinical features with the general stiffness (control points), specific stiffness (MTrPs)
and stiffness change. Finally, we found no association between SWE features with clinical
severity indicators of MPS assessed as pain extent, pain intensity, sensitivity and neck
disability.
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